Search Results - "DOBASHI, Hiroaki"

Refine Results
  1. 1
  2. 2
  3. 3

    Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study by Harigai, Masayoshi, Kaname, Shinya, Tamura, Naoto, Dobashi, Hiroaki, Kubono, Shinichi, Yoshida, Takumitsu

    Published in Modern rheumatology (02-03-2023)
    “…ABSTRACT Objectives This subgroup analysis of the randomized, double-blind, Phase 3 ADVOCATE study evaluated the efficacy and safety of avacopan compared with…”
    Get full text
    Journal Article
  4. 4

    Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy by Sugihara, Koichi, Wakiya, Risa, Shimada, Hiromi, Kameda, Tomohiro, Nakashima, Shusaku, Kato, Mikiya, Miyagi, Taichi, Mizusaki, Mao, Mino, Rina, Nomura, Yumi, Inoo, Masayuki, Kadowaki, Norimitsu, Dobashi, Hiroaki

    Published in Internal Medicine (01-07-2022)
    “…Objective To investigate the serum total antibody (immunoglobulin M and immunoglobulin G) titre against severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose by Wakiya, Risa, Kameda, Tomohiro, Nakashima, Shusaku, Shimada, Hiromi, Mansour, Mai Mahmoud Fahmy, Kato, Mikiya, Miyagi, Taichi, Kadowaki, Norimitsu, Dobashi, Hiroaki

    Published in Internal Medicine (01-09-2020)
    “…Objective Hydroxychloroquine (HCQ) has been prescribed in Japan only relatively recently and is recommended for the treatment of skin lesions, arthritis and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    A multicentre study of clinical features and HLA typing in Japanese patients with ankylosing spondylitis by Tada, Kurisu, Dobashi, Hiroaki, Taniguchi, Yoshinori, Shuto, Toshihide, Hagimori, Kohei, Hayashi, Eri, Inoue, Hisashi, Kobayashi, Shigeto, Ymaji, Ken, Tamura, Naoto

    Published in Modern rheumatology (02-03-2023)
    “…ABSTRACT Objectives Due to the low prevalence of HLA-B27 and ankylosing spondylitis (AS) in Japan, rheumatologists have little experience with AS. We conducted…”
    Get full text
    Journal Article
  16. 16

    Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease by Mitamura, Katsuya, Arai-Okuda, Hanae, Yamamoto, Yuka, Norikane, Takashi, Takami, Yasukage, Fujimoto, Kengo, Wakiya, Risa, Ozaki, Hiroki, Dobashi, Hiroaki, Nishiyama, Yoshihiro

    Published in EJNMMI research (09-12-2020)
    “…Purpose The efficiency of [ 18 F]FDG PET/CT using volume-based indices was evaluated to assess the disease activity and response to therapy in patients with…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1) by Kameda, Hideto, Hagimori, Kohei, Morisaki, Yoji, Holzkämper, Thorsten, Konomi, Ayako, Dobashi, Hiroaki

    Published in Rheumatology and therapy. (01-12-2023)
    “…Introduction The efficacy and safety of ixekizumab, an anti-interleukin-17A antibody, in patients with severe symptoms of psoriatic arthritis are largely…”
    Get full text
    Journal Article
  20. 20